Knowledge hub

News

Ardigen at PMWC 2023

Mariola Fotin-Mleczek, PhD, Has Joined Ardigen’s Scientific Board
Ardigen supports JUMP-CP Consortium – The World’s Largest Public Cell Painting Dataset
Agnieszka Blum, MD, PhD, Promoted to the Ardigen Management Board
Prof. Dr. med. Michael Schmitt, MHBA in Ardigen’s Scientific Board
Łukasz Dutkiewicz, PhD Welcomed in Ardigen as a Business Development Director
Discover Our Gene Regulation Platform
Unconventional γδ T cells as allogeneic cellular products in immunotherapies for cancer.
Boost Your Way to Successful Therapy: AI for Drug Discovery Days
News

Ardigen – New Corporate Identity

Happy Holidays 2021
Prof. Olivera Finn joined Ardigen’s Scientific Board
Ardigen has received funding for the development of the AI-powered Microbiome Platform.
Gut microbiota’s road to clinical utilization. From bathroom to bedside.
Off-the-Shelf allogeneic cellular immunotherapies for cancer
Dr. Aleksandra Walczak joined Ardigen’s Scientific Board to support the development of AI platforms for the discovery of cell therapies.
Ardigen obtained a Great Place to Work certification
Current and future directions in CAR-T and TCR-T cell therapies against solid tumors